Table 3. Correlation between miR-203a-3p expression and cumulative miR-203a BSs on the circRNAs in individual patients during secukinumab treatment.
Patient | R | R squared | p-value | Deviation from zero? |
---|---|---|---|---|
1 | 0.9841 | 0.9684 | 0.0024 | significant |
2 | 0.9308 | 0.8664 | 0.0070 | significant |
3 | 0.4862 | 0.2364 | 0.4063 | ns |
4 | 0.7336 | 0.5381 | 0.0970 | ns |
5 | 0.9038 | 0.8169 | 0.0134 | significant |
6 | 0.7612 | 0.5794 | 0.0788 | ns |
7 | 0.8555 | 0.7318 | 0.0298 | significant |
8 | 0.9864 | 0.9730 | 0.0003 | significant |
9 | 0.8410 | 0.7072 | 0.0359 | significant |
10 | 0.8002 | 0.6403 | 0.0559 | ns |
11 | 0.9426 | 0.8885 | 0.0048 | significant |
12 | 0.6151 | 0.3783 | 0.1937 | ns |
13 | 0.8744 | 0.7646 | 0.0227 | significant |
14 | 0.9135 | 0.8345 | 0.0301 | significant |
Values of the estimated numbers of miR-203a BSs on the circRNAs were log2-transformed. Ns = not significant.